Becaplermin

BIOLOGICAL2 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., McMaster University

Conditions

Diabetic FootDiabetic NeuropathiesFoot UlcerFoot Ulcer, DiabeticSkin UlcerVenous Ulcer

Phase 3

A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX

TerminatedNCT00034788

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Diabetic Foot, Diabetic Neuropathies, Foot Ulcer +1

Start: 2000-12-31End: 2004-02-29Updated: 2011-06-08

Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

McMaster UniversityFoot Ulcer, Diabetic, Venous Ulcer

Start: 2018-08-31End: 2020-09-30Target: 80Updated: 2018-04-09

Related Papers

Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing: Protocol for a Randomized Controlled Proof-of-Concept Study

JMIR Research Protocols2018-04-2711 citations